ABVC vs CHD · rev $509.6K vs P/E 32, rev $6.11B
ABVC Biopharma Inc (ABVC) versus Church & Dwight Company Inc (CHD) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
ABVC currently screens at market cap $35.9M. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Not investment advice. Open the ABVC and CHD stock pages for the full models.
Not investment advice.